₹9.55
■ +0 +0.00%
17 Jul 2026
BSE Listed
Cian Healthcare Limited (542678)
Volume: 0Avg Vol 1W: 3,200Avg Vol 1M: 72,27352W Range:₹3.11₹9.55
Key Ratios
Checked just nowMarket Cap₹49 Cr
Current Price₹9.55
Previous Close₹9.55
High / Low (52w)₹9.55 / ₹3.11
Volume0
Avg Vol (1W)3,200
Avg Vol (1M)72,273
Stock P/E198
Book Value₹23.1
Dividend Yield—
ROE—
ROA—
Revenue (TTM)—
Revenue Growth—
Profit Margin—
Total Debt—
Shares Outstanding—
Face Value—
EPS (TTM)—
P/B0.86
Debt / Equity1.22
50 DMA₹6.17
200 DMA₹4.65
Day change+0.00%
Price Chart
₹9.55▲ 149.35% · 1Y
2025-07-172026-07-17
20-day avg volume: 77K shares
Pros
- Company is almost debt-free.
- Stock trades below its book value.
Cons
- Revenue fell 50% YoY.
- Company is loss-making at the latest annual result.
- Stock trades at a high P/E of 198.
Profit & Loss (Annual)
| Metric | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|
| Revenue | ₹58 Cr | ₹74 Cr | ₹78 Cr | ₹69 Cr | ₹62 Cr | ₹31 Cr |
| EBITDA | ₹4 Cr | ₹9 Cr | ₹1 Cr | ₹8 Cr | ₹6 Cr | ₹-11 Cr |
| Net Profit | ₹-4 Cr | ₹0 Cr | ₹-6 Cr | ₹2 Cr | ₹1 Cr | ₹-26 Cr |
| EPS | -1.62 | 0.02 | -2.21 | 0.81 | 0.34 | -10.39 |
Balance Sheet
| Metric | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|
| Total Assets | ₹157 Cr | ₹157 Cr | ₹166 Cr | ₹160 Cr | ₹161 Cr | ₹156 Cr |
| Total Liabilities | ₹98 Cr | ₹99 Cr | ₹110 Cr | ₹103 Cr | ₹103 Cr | ₹124 Cr |
| Equity | ₹58 Cr | ₹58 Cr | ₹55 Cr | ₹57 Cr | ₹58 Cr | ₹32 Cr |
| Total Debt | — | — | — | — | — | — |
Cash Flow
| Metric | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|
| Operating | ₹-7 Cr | ₹6 Cr | ₹9 Cr | ₹5 Cr | ₹12 Cr | ₹21 Cr |
| Investing | ₹-27 Cr | ₹3 Cr | ₹1 Cr | ₹3 Cr | ₹-1 Cr | ₹0 Cr |
| Financing | ₹36 Cr | ₹-10 Cr | ₹-11 Cr | ₹-7 Cr | ₹-10 Cr | ₹-4 Cr |
| Free Cash Flow | ₹-7 Cr | ₹6 Cr | ₹9 Cr | ₹5 Cr | ₹12 Cr | ₹21 Cr |
Shareholding
Promoter 95% Institutions 0% Public 5%
Efficiency & Working Capital
ROCE—
Interest Coverage-3.5
Dividend Payout—
Debtor Days206 d
Inventory Days309 d
Payable Days494 d
Cash Conversion Cycle21 d
Working Capital Days515 d
Shareholding Details
As of 2026-03-31
Promoter95%
FII0%
DII0%
Institutions0%
Public5%
Promoter Pledge0%
No. of Shareholders1,683
Shareholding Pattern
Quarterly — figures in %. Latest 12 quarters.
| Period | Dec 2021 | Mar 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Sept 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Mar 2025 | Sept 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | — | 66.3% | 66.3% | 66.3% | 51.9% | 49.6% | 27.1% | 27.1% | 27.1% | 27.1% | 27.1% | 95% |
| FIIs | — | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| DIIs | — | 0% | 0% | 0.8% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | — | 33.7% | 33.7% | 33% | 48.1% | 50.4% | 72.9% | 72.9% | 72.9% | 72.9% | 72.9% | 5% |
| Promoter Pledge | — | 34.1% | 34.1% | 34.1% | 18% | 18.8% | 47.8% | 99.9% | 34.5% | 34.5% | 34.5% | 0% |
| No. of Shareholders | 396 | 392 | 424 | 418 | 454 | 672 | 880 | 831 | 1,088 | 1,501 | 1,662 | 1,683 |
Returns History (ROE / ROCE / ROA)
| Period | ROE | ROCE | ROA | P/E |
|---|---|---|---|---|
| 202503 | — | — | — | — |
Major Shareholders (>1%)
| Name | Category | Stake | Shares |
|---|---|---|---|
| Ananta Medicare Limited | Shareholding of Promoter and Promoter Group | 55% | 1.38 Cr |
| Rajesh Jain | Shareholding of Promoter and Promoter Group | 21% | 52,50,000 |
| Pradeep Kumar Jain | Shareholding of Promoter and Promoter Group | 19% | 47,50,000 |
| Rachit Malhotra In Capacity Of Trustee | Public Shareholding | 0% | 539 |
Promoter Pledges
| Holder | Pledged Shares | % of Holding | As of |
|---|---|---|---|
| Rajesh Jain | 0 | 0% | 2026-03-31 |
| Ananta Medicare Limited | 0 | 0% | 2026-03-31 |
| Pradeep Kumar Jain | 0 | 0% | 2026-03-31 |
| Rachit Malhotra In Capacity Of Trustee | 0 | 0% | 2026-03-31 |
| Suraj Shriniwas Zanwar | 16,16,077 | 64.1% | 2025-09-30 |
| Kavita Suraj Zanwar | 3,00,000 | 99.3% | 2025-09-30 |
| Pankaj Shriniwas Zanwar | 4,20,000 | 12.2% | 2025-09-30 |
| Shakuntala Shriniwas Zanwar | 0 | 0% | 2025-09-30 |
| Girish Dargad | 0 | 0% | 2025-09-30 |
| Prakashchandra Rathi | 0 | 0% | 2025-09-30 |
| Sudhaben Prafulchandra Vaidya | 0 | 0% | 2025-09-30 |
| Vikas Kumar Ekka | 0 | 0% | 2025-09-30 |
Board of Directors
| Name | Designation | Year |
|---|---|---|
| Suraj Zanwar | Managing Director | 2025 |
| Sunil Saini | Independent Director | 2025 |
| Santosh Pimparkar | Director | 2025 |
| Bhushan Ramesh Kulkarni | Company Sec. & Compli. Officer | 2025 |
Segments — Geography
| Region | Revenue | Share |
|---|---|---|
| Domestic | ₹27 Cr | 87.1% |
| Export | ₹4 Cr | 12.9% |
Capital Structure (₹ Cr)
| Year | Face Value | Authorised | Issued | Paid-up |
|---|---|---|---|---|
| 2025 | ₹10 | 25 | 25 | 25 |
Related-Party Transactions (₹ Cr)
| Year | Subsidiaries | Associates | JV | KMP | Others | Total |
|---|---|---|---|---|---|---|
| 2025 | 6 | 0 | 0 | 16 | 0 | 21 |
| 2025 | 0 | 0 | 0 | 2 | 0 | 2 |
| 2025 | 4 | 0 | 0 | 14 | 0 | 17 |
Substantial Acquisitions (SAST)
3 disclosure(s)
Market06/02/2024 · 7,40,000
Market18/01/2024 · 7,00,000
Market10/01/2024 · 8,00,000
Company Information
🌐 www.cian.co ↗
📍 Milkat No 3339 BNo 1 Phursungi, From Southside CS NO 227/2, Pune, Maharashtra, 412308
Technical AnalysisPremium
Technical analysis (Premium)
Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.
More stocks
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search